This content is from: European Union Eli Lilly counsel reflects on twists and turns of Alimta lawsuits Ivan Burnside tells Managing IP how the pemetrexed case on salt substitution shook up European patent law By Charlotte Kilpatrick December 01 2020
This content is from: United States COVID pledge co-founder: ‘Only sharing can effect global change’ By Rani Mehta December 01 2020
This content is from: European Union UK lawyers avoid being ‘short changed’ over audience rights By Max Walters December 01 2020
This content is from: China Vigilance key for drug innovators under China linkage regime By Karry Lai December 01 2020
This content is from: United States How Intel’s Vanessa Bailey fights for IP policy – and diversity By Rani Mehta November 30 2020
This content is from: United States Arthrex chief stoked by SCOTUS suit, but not at disquiet caused By Patrick Wingrove November 27 2020
This content is from: International 'You have to compromise': Avanci on licensing challenges By Max Walters November 27 2020
This content is from: New Zealand The importance of providing sufficient evidence in invalidation proceedings By Kathleen Henning November 26 2020
This content is from: China What is the impact of AI on patent infringement? By Jian Zhang & Jinhua Deng November 19 2020
This content is from: China China embraces a pharmaceutical patent linkage system By Jie Zhao November 09 2020
This content is from: United States Analysing the impact of survey evidence on acquired distinctiveness rulings By Jerry Jakubovic & Karen Artz Ash November 06 2020
.svg)
